Abstract
The analysis of clinical efficacy of Tonsilgon N was performed on the basis of clinical observations of 35 sickly children with chronic tonsillitis (single-agent trial). Following the analysis the authors established the advisability of Tonsilgon N administration in treatment of the compensated form of chronic tonsillitis in sickly and chronically ailing children. The reduced frequency of acute respiratory viral diseases and the decreased risk of its transition into the decompensated form of chronic tonsillitis have also been recorded.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
